If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Subscription to raise £5 million

24 Mar 2021 07:01

RNS Number : 2583T
Circassia Group Plc
24 March 2021
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

24 March 2021

Circassia Group plc

("Circassia" or the "Company" and, together with its subsidiaries, the "Group")Subscription to raise £5 million

Circassia Group plc today announces that it has entered into subscription agreements (the "Agreements") with three of its major institutional shareholders Harwood Capital, Richard Griffiths and Lombard Odier Asset Management to raise a total of £5 million in gross proceeds (the "Subscription") to provide capital investment, to strengthen the Company's balance sheet and provide it with additional liquidity to supplement the continuance of its operational business within the wider Group.

The Group today also announced its audited results for the 12 months ended 31 December 2020 and a post-period update.

Further details of the Agreements

Under the terms of the Agreements, Lombard Odier Asset Management, North Atlantic Smaller Companies Investment Trust plc (to which Harwood Capital acts as investment manager) and Richard Griffiths have subscribed for a total of 20,000,000 new ordinary shares of 0.08 pence each in Circassia (the "Subscription Shares") at a price of 25p per share. The subscription price represents a discount of approximately 10.7 per cent. to the closing mid-market price on 23 March 2021, the latest practicable date prior to this announcement.

The amounts subscribed by the various parties are set out in the table below:

 

Number of Subscription

Shares

Amount

subscribed

Lombard Odier Asset Management

10,000,000

£2,500,000

Richard Griffiths

6,000,000

£1,500,000

North Atlantic Smaller Companies Investment Trust plc

4,000,000

£1,000,000

 

 

Ian Johnson, Executive Chairman of Circassia, said:

"I am grateful for the support of three of our largest shareholders at this time as we continue to invest in the Niox® business. We have a market leading product for the diagnosis and management of asthma and are committing to our aim of delivering greater value to shareholders."

 

Related Party Transactions

The participation in the Subscription by each of Harwood and Richard Griffiths, both of whom are substantial shareholders as defined in the AIM Rules for Companies (the "AIM Rules"), each constitutes a related party transaction under Rule 13 of the AIM Rules. The independent Directors, being the Board members other than Nicholas Mills, consider, having consulted with N+1 Singer as the Company's nominated adviser, that the terms of the transactions with each of Harwood and Richard Griffiths are fair and reasonable insofar as shareholders are concerned.

Application for Admission

Application has been made to the London Stock Exchange for the Subscription Shares to be admitted to trading on AIM. Admission of and dealings in the Subscription Shares is expected to commence at 8.00 a.m. on 25 March 2021.

Following Admission, the Company will have 417,661,192 Ordinary Shares of 0.08p in issue, each carrying one voting right. No shares are held in treasury.

The above figure may therefore be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

General

All Subscription Shares will be issued credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares, including the right to receive all distributions declared on or after the date on which they are issued.

 

 

-Ends-

For further information, please contact:

Circassia Group plc

 

Ian Johnson, Executive Chairman

 

 

c/o N+1 Singer

Michael Roller, CFO

N+1 Singer (Nominated Adviser and Broker)Aubrey Powell / Jen Boorer / Hannah Woodley

Tel: +44 (0) 20 7496 3000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUORURASUOUUR
Date   Source Headline
31st Jan 20184:03 pmRNSTotal Voting Rights
17th Jan 20182:42 pmRNSBlock Listing Six Monthly Return
17th Jan 20182:37 pmRNSNotification of Major Holdings
8th Jan 20187:00 amRNSTR-1: Notification of major holdings
5th Jan 20185:31 pmRNSHolding(s) in Company
29th Dec 20177:00 amRNSTotal Voting Rights
19th Dec 20175:48 pmRNSNotification of Major Holdings
4th Dec 20177:00 amRNSTudorza® Meets Primary Endpoints in ASCENT Study
30th Nov 20172:53 pmRNSTotal Voting Rights
29th Nov 20177:00 amRNSCircassia Welcomes New NICEAsthma Guidelines
31st Oct 20175:18 pmRNSTotal Voting Rights Update
16th Oct 201711:39 amRNSNotification of Major Holdings
29th Sep 201712:13 pmRNSTotal Voting Rights Update
27th Sep 20177:00 amRNSInterim results six months ended 30 June 2017
18th Sep 20172:52 pmRNSNotification of Major Holdings
18th Sep 20172:19 pmRNSNotification of Major Holdings
12th Sep 20177:00 amRNSEuropean Launch of NIOX VERO® Nasal Mode
7th Sep 20177:00 amRNSPrimary Endpoints Met in AMPLIFY Phase III Study
1st Sep 20175:21 pmRNSNotification of Major Holdings
31st Aug 201712:52 pmRNSTotal Voting Rights
24th Aug 20174:06 pmRNSNotice of Interim Results
31st Jul 20177:00 amRNSTotal Voting Rights Update
21st Jul 20178:52 amRNSNotification of Major Holdings
17th Jul 20176:28 pmRNSDirector/PDMR Shareholding
14th Jul 201712:29 pmRNSNotification of Major Holdings
30th Jun 20177:00 amRNSBlock Listing Six Monthly Return
30th Jun 20177:00 amRNSTotal Voting Rights Update
29th Jun 20176:08 pmRNSNotification of Major Interest in Shares
27th Jun 201711:48 amRNSNotification of Major Interest in Shares
26th Jun 20174:27 pmRNSNotification of Major Interest in Shares
15th Jun 20175:40 pmRNSNotification of Major Interest in Shares
5th Jun 20175:36 pmRNSDirector/PDMR Shareholding
31st May 201710:59 amRNSTotal Voting Rights Update
31st May 20177:00 amRNSBlock Listing Application
26th May 201711:35 amRNSResult of AGM 2017
26th May 20177:00 amRNSHolding(s) in Company
28th Apr 20175:20 pmRNSAnnual Report and Notice of Annual General Meeting
28th Apr 20173:15 pmRNSTotal Voting Rights Update
25th Apr 20177:02 amRNSNon-Executive Director Retirements
25th Apr 20177:00 amRNSPreliminary Results for Year Ended 31 Dec 2016
18th Apr 20176:09 pmRNSHolding(s) in Company
18th Apr 20174:51 pmRNSNotification of Major Interest in Shares
18th Apr 201710:20 amRNSNotification of Major Interest in Shares
18th Apr 20177:00 amRNSTop-Line Results of House Dust Mite Allergy Study
13th Apr 20176:02 pmRNSHolding(s) in Company
13th Apr 20175:57 pmRNSHolding(s) in Company
12th Apr 20175:34 pmRNSNotification of Major Interest in Shares
12th Apr 20179:00 amRNSNotice of Results
12th Apr 20178:30 amRNSCompletion of Transaction and Admission to Trading
11th Apr 20179:00 amRNSEarly Termination of HSR Waiting Period Granted

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.